Safety and tolerability of inhaled molgramostim in autoimmune pulmonary alveolar proteinosis (aPAP)
F. Bonella (Essen, Germany), J. Bennett (Raleigh, United States), B. Chowdhury (Austin, United States), D. Desai (Austin, United States)
Source: International Congress 2022 – Chronic cough, airway diseases and methods
Session: Chronic cough, airway diseases and methods
Session type: Thematic Poster
Number: 176
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Bonella (Essen, Germany), J. Bennett (Raleigh, United States), B. Chowdhury (Austin, United States), D. Desai (Austin, United States). Safety and tolerability of inhaled molgramostim in autoimmune pulmonary alveolar proteinosis (aPAP). 176
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|